CHF177.20
0.11% yesterday
SIX Swiss Exchange, Jun 13, 05:31 pm CET
ISIN
CH0012627250
Symbol
HBMN
Sector
Industry

HBM Healthcare Investments Target price 2025 - Analyst rating & recommendation

HBM Healthcare Investments Classifications & Recommendation:

Buy
100%

HBM Healthcare Investments Price Target

Target Price CHF233.50
Price CHF177.20
Potential
Number of Estimates 2
2 Analysts have issued a price target HBM Healthcare Investments 2026 . The average HBM Healthcare Investments target price is CHF233.50. This is higher than the current stock price. The highest price target is
CHF236.00 33.18%
register free of charge
, the lowest is
CHF231.00 30.36%
register free of charge
.
A rating was issued by 2 analysts: 2 Analysts recommend HBM Healthcare Investments to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the HBM Healthcare Investments stock has an average upside potential 2026 of . Most analysts recommend the HBM Healthcare Investments stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Mar '25 2026
Estimates
Revenue Million CHF 42.01 132.30
81.16% 214.93%
Net Margin 44.13% 77.78%
1,047.62% 76.24%

1 Analyst has issued a sales forecast HBM Healthcare Investments 2026 . The average HBM Healthcare Investments sales estimate is

CHF132m
Unlock
. This is
214.93% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CHF132m 214.93%
Unlock
, the lowest is
CHF132m 214.93%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 CHF42.0m 81.16%
2026
CHF132m 214.93%
Unlock
2027
CHF134m 1.59%
Unlock

1 Analyst has issued a net profit forecast HBM Healthcare Investments 2026 . The average HBM Healthcare Investments net profit estimate is

CHF103m
Unlock
. This is
455.02% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CHF103m 455.02%
Unlock
, the lowest is
CHF103m 455.02%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 CHF18.5m 1,816.67%
2026
CHF103m 455.02%
Unlock
2027
CHF105m 2.03%
Unlock

Net Margin

2025 44.13% 1,047.62%
2026
77.78% 76.24%
Unlock
2027
78.12% 0.44%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Mar '25 2026
Estimates
Earnings Per Share CHF 2.72 15.29
1,800.00% 462.13%
P/E 11.59
EV/Sales 9.74

1 Analysts have issued a HBM Healthcare Investments forecast for earnings per share. The average HBM Healthcare Investments EPS is

CHF15.29
Unlock
. This is
458.03% higher
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
CHF15.29 458.03%
Unlock
, the lowest is
CHF15.29 458.03%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 CHF2.72 1,800.00%
2026
CHF15.29 462.13%
Unlock
2027
CHF15.60 2.03%
Unlock

P/E ratio

Current 64.67 104.65%
2026
11.59 82.08%
Unlock
2027
11.36 1.98%
Unlock

Based on analysts' sales estimates for 2026, the HBM Healthcare Investments stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 30.67 53.82%
2026
9.74 68.25%
Unlock
2027
9.59 1.56%
Unlock

P/S ratio

Current 28.36 54.68%
2026
9.00 68.25%
Unlock
2027
8.86 1.56%
Unlock

Current HBM Healthcare Investments Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
BAADER HELVEA EQUITY RESEARCH
Locked
Locked
Locked Jan 19 2025
BAADER HELVEA EQUITY RESEARCH
Locked
Locked
Locked Oct 20 2024
Analyst Rating Date
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
Locked
Jan 19 2025
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
Locked
Oct 20 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today